Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeptune-Calculus Income & Growth Regulatory News (NEP)

  • There is currently no data for NEP

Interim Management Statement

19 May 2009 15:40

RNS Number : 5175S
Neptune-Calculus Income &Growth VCT
19 May 2009
 



Neptune Calculus Income and Growth VCT plc Interim Management Statement

Neptune Calculus Income and Growth VCT plc (the company)

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2009

In accordance with rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, Neptune Calculus Income and Growth VCT plc presents an Interim Management Statement for the quarter ended 31 March 2009. The statement also includes relevant financial information between the end of the period and the date of this statement.

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 March 2009

At 31 December 2008

Ordinary Shares

Ordinary Shares

Ordinary Shares

Ordinary Shares

 

 

Net assets attributable to shareholders

£3,147,000

 

£6,411,800

£3,196,000

£6,472,000

Shares in issue

4,100,806

8,776,764

4,100,806

8,776,764

Net asset value per share

76.73 pence

73.05 pence

77.94 pence

73.74 pence

Cumulative dividends paid and proposed

8.0 pence

3.9 pence

8.0 pence

3.9 pence

At as 30 April 2009 the net Asset value per Ordinary share was 82.42p and the net asset value per C Ordinary share was 76.50p prior to conversion of the C Ordinary shares to Ordinary shares.

C SHARE CONVERSION

On 30 April 2009 the 8,776,764 C Ordinary shares were converted into 8,300,185 Ordinary shares taking the total number of Ordinary shares in issue to 12,400,991. The net asset value per Ordinary Share on 30 April 2009 following conversion of the C Ordinary shares to Ordinary shares was 81.4p

PERFORMANCE 

In a quarter of continuing difficult economic conditions during which the UK economy contracted by approximately 1.9%, the net asset value per Ordinary Share fell by 1.55% and the net asset value  per C Ordinary share fell by 0.94%. Stock markets were volatile with company valuations remaining depressed.  However there was some good news. In early March, EpiStem Holdings plc in which the company holds 202,063 shares with a book cost of £250,901 signed a major research and development deal with the Swiss drug marker Novartis which will transform Epistem Holdings plc from a Contract Research Services company into a drug development company with secure funding and a much higher revenue potential. The Epistem share price had increased to £2.55 by 31 March 2009 valuing the investment at £515,260 and by 30 April 2009 the share price had risen to £3.50 valuing the investment at £707,221

INVESTMENT ACTIVITY

During the quarter the Company invested a further £120,000 in Managed Support Services PLC as part of a £6million fundraising to provide funds for the management to exploit acquisition opportunities at the depressed stage of the business cycle. There were no disposals or realisations during the period.

SHARE BUY-BACKS

During the quarter ended 31 March 2009 the company did not buy back any shares.

MATERIAL EVENTS

Other than described above, the Board is not aware of any significant event or transaction which has occurred between 31 March 2009 and the date of publication of this Interim Management Statement which would have a material impact on the financial position of the Company. 

For further information please contact:

John Glencross for Neptune Calculus Income and Growth VCT plc: 020 7493 4940

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUUBWAUPBGCB
Date   Source Headline
24th May 20113:36 pmRNSResult of AGM
18th May 20112:17 pmRNSInterim Management Statement
6th May 20114:33 pmRNSTransaction in Own Shares
5th May 20114:53 pmRNSTransaction in Own Shares
5th May 201112:57 pmRNSAnnual Information Update
22nd Mar 20114:46 pmRNSTransaction in Own Shares
17th Mar 20113:39 pmRNSAnnual Financial Report
10th Mar 20114:07 pmRNSFinal Results
16th Dec 20105:24 pmRNSTransaction in Own Shares
18th Nov 20103:31 pmRNSInterim Management Statement
20th Aug 201012:40 pmRNSHalf Yearly Report
21st May 20102:26 pmRNSResult of AGM
18th May 20109:54 amRNSInterim Management Statement
22nd Apr 20105:03 pmRNSAnnual Information Update
19th Mar 20104:36 pmRNSFinal Results
3rd Nov 200911:54 amRNSInterim Management Statement
15th Sep 20093:22 pmRNSDirector/PDMR Shareholding
18th Aug 20091:39 pmRNSHalf Yearly Results
29th May 20095:41 pmRNSAnnual Information Update
29th May 20093:23 pmRNSResult of AGM
19th May 20093:40 pmRNSInterim Management Statement
30th Apr 200910:25 amRNSConversion of Securities
23rd Apr 20095:30 pmRNSAppointment of broker
24th Mar 20095:25 pmRNSFinal Results
19th Dec 20085:12 pmRNSDirector Dealing
11th Dec 200810:06 amRNSChange of Adviser
11th Nov 20089:46 amRNSInterim Management Statement
22nd Aug 200811:22 amRNSHalf-yearly report and change
19th Aug 20081:37 pmRNSInterim Results
5th Jun 20082:14 pmRNSResult of AGM
27th May 200810:53 amRNSAnnual Information Update
19th May 200812:47 pmRNSInterim Management Statement
8th Apr 20083:19 pmRNSEquity issue and Accounts
19th Mar 20081:31 pmRNSFinal Results
18th Mar 20085:30 pmRNSIssue of Equity
18th Mar 200812:12 pmRNSNet Asset Value(s) Correction
17th Mar 20084:45 pmRNSNet Asset Values
16th Jan 20082:37 pmRNSoffer for subscription
26th Sep 20072:27 pmRNSFSA Document Viewing Facility
21st Sep 200712:16 pmRNSInterim Results
9th Jul 20073:42 pmRNSRule 8.3 Mount Engineering
2nd Jul 20072:50 pmRNSDirectorate Change
22nd Jun 200712:24 pmRNSFSA Document Viewing Facility
25th May 20072:53 pmRNSAnnual Information Update
22nd May 20074:39 pmRNSResult of AGM
21st May 200712:14 pmRNSPre AGM Statement
25th Apr 20072:50 pmRNSNet Asset Value(s)
11th Apr 200710:07 amRNSFSA Document Viewing Facility
22nd Mar 20075:05 pmRNSFinal Results
29th Jan 20079:18 amRNSLetter to Shareholders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.